Works by Matsumoto, Hirotaka

Results: 71
    1
    2

    Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial.

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 6, p. 519, doi. 10.1016/j.cllc.2023.05.008
    By:
    • Kimio Yonesaka;
    • Hidetoshi Hayashi;
    • Atsushi Nakamura;
    • Yuki Sato;
    • Koichi Azuma;
    • Shinya Sakata;
    • Motoko Tachihara;
    • Satoshi Ikeda;
    • Toshihide Yokoyama;
    • Kentaro Ito;
    • Yukihiro Yano;
    • Hirotaka Matsumoto;
    • Haruko Daga;
    • Akito Hata;
    • Kazuko Sakai;
    • Yasutaka Chiba;
    • Kazuto Nishio;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawal
    Publication type:
    Article
    3
    4

    Amputation for histiocytic sarcoma in a cat.

    Published in:
    Journal of Feline Medicine & Surgery, 2012, v. 14, n. 2, p. 147, doi. 10.1177/1098612X11429226
    By:
    • Teshima, Takahiro;
    • Hata, Takashi;
    • Nezu, Yoko;
    • Michishita, Masaki;
    • Matsumoto, Hirotaka;
    • Mizutani, Hisashi;
    • Takahashi, Kimimasa;
    • Koyama, Hidekazu
    Publication type:
    Article
    5
    6
    7
    8

    Hepatocellular carcinoma in a young dog.

    Published in:
    2013
    By:
    • Teshima, Takahiro;
    • Matsumoto, Hirotaka;
    • Kae Shigihara;
    • Sawada, Harumi;
    • Michishita, Masaki;
    • Takahashi, Kimimasa;
    • Koyama, Hidekazu
    Publication type:
    Case Study
    9
    10
    11
    12
    13
    14
    15

    Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD.

    Published in:
    Annals of Neurology, 2023, v. 93, n. 2, p. 303, doi. 10.1002/ana.26510
    By:
    • Miyamoto, Kengo;
    • Saiki, Shinji;
    • Matsumoto, Hirotaka;
    • Suzuki, Ayami;
    • Yamashita, Yuri;
    • Iseki, Tatou;
    • Ueno, Shin‐Ichi;
    • Shiina, Kenta;
    • Kataura, Tetsushi;
    • Kamagata, Koji;
    • Imamichi, Yoko;
    • Sasazawa, Yukiko;
    • Fujimaki, Motoki;
    • Akamatsu, Wado;
    • Hattori, Nobutaka
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Integrative genomic and proteomic analyses identifies glycerol-3-phosphate acyltransferase as a target of low-dose ionizing radiation in EBV infected-B cells.

    Published in:
    International Journal of Radiation Biology, 2016, v. 92, n. 1, p. 24, doi. 10.3109/09553002.2015.1106021
    By:
    • Tabe, Yoko;
    • Hatanaka, Yasuhito;
    • Nakashiro, Mayumi;
    • Sekihara, Kazumasa;
    • Yamamoto, Shinichi;
    • Matsushita, Hiromichi;
    • Kazuno, Saiko;
    • Fujimura, Tsutomu;
    • Ikegami, Takako;
    • Nakanaga, Keita;
    • Matsumoto, Hirotaka;
    • Ueno, Takashi;
    • Aoki, Junken;
    • Yokomizo, Takehiko;
    • Konopleva, Marina;
    • Andreeff, Michael;
    • Miida, Takashi;
    • Iwabuchi, Kazuhisa;
    • Sasai, Keisuke
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Influence of social isolation and loneliness on the prognosis of advanced lung cancer patients: a prospective cohort study.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 7, p. 6045, doi. 10.1007/s00520-022-07026-1
    By:
    • Takemura, Tomoyasu;
    • Kataoka, Yuki;
    • Ashi, Nanami;
    • Shirakawa, Chigusa;
    • Okazaki, Koya;
    • Sakurai, Azusa;
    • Imakita, Takuma;
    • Ikegaki, Shunkichi;
    • Matsumoto, Hirotaka;
    • Saito, Emiko;
    • Takata, Hirohito;
    • Kaku, Sawako;
    • Wada, Nobuko;
    • Shinomiya, Mariko;
    • Otoshi, Takehiro;
    • Shimada, Masatoshi;
    • Nikaido, Junichi;
    • Iki, Reika;
    • Hirano, Katsuya;
    • Hirai, Tomoyuki
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35

    Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005).

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 7, p. 643, doi. 10.1016/j.cllc.2024.07.014
    By:
    • Hayato Kawachi;
    • Motohiro Tamiya;
    • Yuko Oya;
    • Go Saito;
    • Yoshihiko Taniguchi;
    • Hirotaka Matsumoto;
    • Yuki Sato;
    • Taiichiro Otsuki;
    • Hidekazu Suzuki;
    • Yasushi Fukuda;
    • Satoshi Tanaka;
    • Yoko Tsukita;
    • Junji Uchida;
    • Yoshihiko Sakata;
    • Yuki Nakatani;
    • Ryota Shibaki;
    • Daisuke Arai;
    • Asuka Okada;
    • Satoshi Hara;
    • Koichi Takayama
    Publication type:
    Article
    36

    Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

    Published in:
    2020
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Makio, Takeshi;
    • Hara, Satoshi
    Publication type:
    journal article
    37
    38
    39
    40
    41

    Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58186-7
    By:
    • Tanaka, Kentaro;
    • Sugisaka, Jun;
    • Shiraishi, Yoshimasa;
    • Watanabe, Yasutaka;
    • Daga, Haruko;
    • Azuma, Koichi;
    • Nishino, Kazumi;
    • Mori, Masahide;
    • Ota, Takayo;
    • Saito, Haruhiro;
    • Hata, Akito;
    • Sakaguchi, Tadashi;
    • Kozuki, Toshiyuki;
    • Akamatsu, Hiroaki;
    • Matsumoto, Hirotaka;
    • Tachihara, Motoko;
    • Wakuda, Kazushige;
    • Sato, Yuki;
    • Ozaki, Tomohiro;
    • Tsuchiya-Kawano, Yuko
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50